Benzinga | Aug 4, 2020 04:25PM EDT

Aptose Biosciences Q2 EPS $(0.21) Misses $(0.15) Estimate

Aptose Biosciences (NASDAQ:APTO) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.15) by 40 percent. This is a 61.54 percent decrease over losses of $(0.13) per share from the same period last year.